2017-18 Global Cord Blood Banking Industry Report
Market Size, Segments, Storage Rates, Utilization, and Projections Through 2022
The 265-page report reveals key forces affecting the industry, presenting trend rate data for cord blood and tissue clinical trials, patents, grants, and scientific publications.
It reveals public and private storage counts for cord blood and tissue on a global basis, as well as market size metrics for the public and private sectors, with five-year projections through 2022.
Over the past few years, the cord blood banking industry has substantially matured and consolidated, creating both threats and opportunities for the industry. Serious threats to the industry include low rates of utilization for stored cord blood, expensive cord blood transplantation procedures, difficulty educating obstetricians about cellular therapies, and an increasing trend toward industry consolidation.
However, there are also emerging opportunities for the industry, such as accelerated regulatory pathways for cell therapies in leading countries worldwide, including the U.S., Japan, South Korea, and EU.
Cord blood banks are also diversifying into new types of stem cell storage, including cord tissue, placental tissue, amniotic products, and more. With the introduction of these new types of stem cell storage, cord blood storage counts are becoming an outdated metric and “Revenue Generating Units” (RGUs) is becoming a more valuable term.
*Claim the report by this Friday, November 10th, and get a FREE license upgrade ($1,000 value). Select a "Single-User License" during checkout and you will be emailed a Global Use License code within 24 hours.
